Gara Jalqabaatti › Non-Hodgkin Lymphoma › Distaarikii Koloombiyaa › Washington
Qorannoo klinikaalii Non-Hodgkin Lymphoma Washington, DC keessatti
Qorannoo 18 Non-Hodgkin Lymphoma f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- American Oncology Partners of Maryland Pa, Bethesda · Miili 7 fagaatti
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
- GC2202 Study Site 111, Bethesda · Miili 7 fagaatti
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Tissue Collection for Studies of Lymph Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraQorannoo ilaalaa
- Walter Reed National Military Medical Center, Bethesda · Miili 7 fagaatti
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
- Medstar Georgetown University Hospital, Washington D.C.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Children's National Medical Center, Washington D.C.
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Partners of Maryland, PA, Bethesda · Miili 7 fagaatti
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Namoota walitti qabaa jiraSadarkaa 3
- MedStar Georgetown University Hospital, Washington D.C.
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · Miili 7 fagaatti
- Nih/Nhlbi, Bethesda · Miili 7 fagaatti
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · Miili 7 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Silver Spring · Miili 7 fagaatti
- Massive Bio SYNERGY-AI site, Bethesda · Miili 7 fagaatti
Qorannoo Non-Hodgkin Lymphoma magaalota biroo keessatti
- New York City, NYQorannoo 31
- Houston, TXQorannoo 31
- Boston, MAQorannoo 26
- Nashville, TNQorannoo 21
- Philadelphia, PAQorannoo 20
- Baldwin Park, CAQorannoo 19
- Chicago, ILQorannoo 18
- Atlanta, GAQorannoo 18
- Milwaukee, WIQorannoo 18
- Columbus, OHQorannoo 18
- Dallas, TXQorannoo 17
- Seattle, WAQorannoo 16
Qorannoo biroo Washington keessatti
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 55
- Saree OljooQorannoo 46
- Kansara MetastatikiiQorannoo 43
- Dhibee QaraQorannoo 41
- Kansarii ProstateQorannoo 38
- ObesityQorannoo 33
- Kansarii ColorectalQorannoo 29
- Dhibee Onneessaa fi DhiigaQorannoo 28
- Dukkana BladderQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 24
- Kansarii OvariiQorannoo 23
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.